In line, in vitro studies suggested that hepatic steatosis sensitizes hepatocytes to TRAIL-mediated apoptosis [33], and that hepatic steatosis may also activate DR5 independently of TRAIL [34]. This evidence concerns the gene TNFSF10 and fatty liver disease.